Call Invite: Nov. 4 @12:30PM ET | Rajesh Aggarwal: The Inevitable Arrives: Technology & Medicine

10/29/20 05:13PM EDT

Call Invite: Nov. 4 @12:30PM ET | Rajesh Aggarwal: The Inevitable Arrives: Technology & Medicine - Raj Aggarwal

The inevitable arrives.

The confluence of economic realities no longer able to tolerate ever rising health care expenses; a trillion-dollar fueled pandemic and an unprecedented deregulatory regime puts the health care industry at the start of transformation unlike anything we have seen since, perhaps, that of transportation in the 1980s. Leading the way is Jefferson Health at Thomas Jefferson University in Philadephia.

Our guest, Dr. Rajesh Aggarwal, in his role as Executive Vice President of Jefferson Strategic Ventures, has focused on health care innovations encompassing digital applications and health IT platforms, virtual and augmented reality solutions, medical devices and interventional robotics and advanced analytics. He has established experience with leading venture, strategic, research and commercial partnership deals for health systems and external parties. Dr. Aggarwal is also Professor in the Division of Minimally Invasive, Metabolic & Bariatric Surgery.

Wednesday, November 4th @12:30PM ET (Add to Outlook Calendar)

CLICK HERE for event details (includes video and materials link)

Some of the topics for discussion include:

  • Dr. Aggarwal has focused his career on integrating technology into clinical practice. Advancements in robotics, telecommunications, AI, voice and VR are dependent in part on good policy, reimbursement and training practices. We will discuss what barriers stand in the way of clinical adoption at scale and how they can be overcome.
  • How we think of telemedicine is changing and likely to advance using more tools as demonstrated by the TDOC-LVGO merger. We will discuss how telemedicine will advance over the next 3-5 years, the role delayed care may play in identifying its limits and how physician training may alter that trajectory.
  • Changes to supervision rules in response to the pandemic seem to suggest an opportunity for integration of technologies like Google Glass into physician training and offer broader access to specialist care. We will look at barriers, real and imagined, to making that a reality.

About Dr. Aggarwal: Dr. Aggarwal undertook his Bachelor’s degree in Social and Political Sciences at the University of Cambridge, medical school at the Royal Free Hospital School of Medicine, University of London, and completed general surgical residency at Imperial College London.

In 2008 he was awarded a PhD degree in virtual reality technologies for surgical education at Imperial College London, under the mentorship of Professor Ara Darzi, current Director of the Institute of Global Health Innovation at Imperial College London, past Parliamentary Under-Secretary of State in the Department of Health in the United Kingdom, and a member of the House of Lords. Whilst working at Imperial with Professor Darzi, Rajesh engaged in collaborative work with the Helen Hamlyn Centre for Design at the Royal College of Art, and Imperial College Business School, comprising redesign of the cardiac arrest trolley, and the Design out Medical Error (or the DoME project), in addition to projects with industrial partners in the fields of simulation, medical devices and robotics.

His current role in strategic ventures and partnerships at Thomas Jefferson University and Jefferson Health, utilizes the 14-hospital health system as a living laboratory, to engage and partner with external companies, to transform health care in its broadest sense. The underlying process is to embed, co-develop and translate novel tools, technologies and platforms, into clinical, academic, reputational and revenue-based impact at Jefferson, which may then be translated to other sites and settings, across the US and beyond. Complete biography here

We look forward to a great discussion.

Emily Evans
Managing Director – Health Policy



Twitter
LinkedIn

© 2024 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.